brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,nivolumab,vinblastine sulfate
seagen,amgen,bms
['hodgkin', 'lymphoma', 'nivo', 's1826']
 plenary #asco23 s1826: randomized phase iii study where adult/pediatric pts with stage iii-iv hodgkins lymphoma randomized to n-avd vs bv-avd
nivo-avd improved 1-yr pfs and efs. 
Assistant Prof | Thoracic Oncology & Phase-I @karmanoscancer | EIC @BTFCancerNews | Previously @MayoCancerCare @gundersenhealth @JeffHealthAb | Tweets my own